Recommendations for pharmacological clinical trials in children with functional constipation: The Rome foundation...

Area of Science:

• Pediatric Gastroenterology
• Clinical Trial Design
• Pharmacological Research

Background:

• Limited high-quality evidence exists for childhood functional constipation (FC) drug efficacy.
• Existing studies often suffer from methodological weaknesses and heterogeneity.
• Standardized recommendations for clinical trial design in pediatric FC are necessary.

Purpose of the Study:

• To establish guidelines for designing robust clinical trials in pediatric functional constipation.
• To improve the quality of evidence for FC treatments in children.
• To inform the development of effective therapeutic strategies.

Main Methods:

• Recommends randomized, double-blind, placebo-controlled, parallel-group trials.
• Inclusion criteria based on Rome IV criteria for FC.
• Advocates for an 8-week minimum trial duration with a run-in period.
• Utilizes the Bristol Stool Scale for stool consistency assessment.

Main Results:

• Defines treatment success as no longer meeting Rome IV criteria for FC.
• Emphasizes age-appropriate endpoint selection for pediatric populations.
• Highlights the need for standardized outcome measures in FC trials.

Conclusions:

• Standardized clinical trial methodologies are crucial for evaluating FC treatments in children.
• Adherence to these recommendations will enhance the reliability of drug efficacy data.
• Improved trial design will facilitate evidence-based treatment decisions for pediatric functional constipation.